The Centre for Maternal, Adolsecent, Reporoductive & Child Health (MARCH) Report by Lawn, Joy et al.
Lawn, Joy; Marchant, Tanya; Ross, David; Marston, Cicely; Fil-
ippi, V; Chico, Matthew; Yeung, Shunmay The Centre for Maternal,
Adolescent, Reproductive & Child Health (MARCH) at the London
School of Hygiene & Tropical Medicine; (2014) The Centre for Mater-
nal, Adolsecent, Reporoductive & Child Health (MARCH) Report.
Other. London School of Hygiene & Tropical Medicine.
Downloaded from: http://researchonline.lshtm.ac.uk/2061184/
DOI:
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
1 2
Improving health worldwide September 2014 Im
pr
ov
in
g 
w
om
en
’s
 a
nd
 c
hi
ld
re
n’
s 
he
al
th
 w
or
ld
w
id
e
MARCH Centre for Maternal, Adolescent,  
Reproductive & Child Health
London School of Hygiene & Tropical Medicine
Keppel Street, London WC1E 7HT
Tel: +44 (0)20 7636 8636
Email: march@lshtm.ac.uk
Web: http://march.lshtm.ac.uk
Twitter: @MARCH_LSHTM
  School age Pr
esc
ho
ol 
   
   
In
fa
nc
y 
  
  
  
  
N
eo
na
ta
l
CChildren
…survive and thrive
  P
rec
once
ption            Pregnancy      B
irth    BBirths
…wanted and safe
   
   
   
  
  
  
  
 R
ep
ro
du
ct
iv
e 
ye
ar
s
A
dolescence
AAdolescents 
and young people
...healthy transitions
More than 150 
public health and research 
experts working around 
the world on reproductive, 
maternal, newborn, child 
and adolescent health.
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Delivering on our promises for 
women and children worldwide
Contents
9 million deaths each year 
of women, babies and children two-
thirds around the time of birth. The 
largest mortality burden at the end 
of the MDG era.
At a time of global concern over emerging infectious 
and chronic diseases, it is important to remember 
that millions of women and children continue to 
die every year from conditions that are easily 
preventable and treatable. 
Despite progress on many fronts, this is a major unfinished agenda 
from the UN Millennium Development Goals, so it is welcome that 
donors, including the UK Department for International Development, 
are now taking a strong lead on women and girls. This approach 
also makes economic sense. According to a recent Lancet 
Commission report, investing in women’s and children’s health, and 
particularly in family planning, care at birth, child and adolescent 
health, can give a nine-fold return, and reduce the burden on  
health systems. 
Researchers at the London School of Hygiene & Tropical Medicine 
have long been active in women’s and children’s health, and in 
2009 the School established the MARCH Centre to focus efforts 
in this area, with founding directors Professor Oona Campbell and 
Professor Pat Doyle, and now expanding under the leadership of 
Professor Joy Lawn. Today, the Centre includes more than 150 
researchers working on critical issues of adolescence, births, and 
child health, spanning the full spectrum of research expertise 
in infectious and non-communicable diseases, mental health, 
evaluation and education. MARCH also provides a coordinated hub 
for knowledge translation, to improve policy and decision making, 
working with a range of government and charitable organisations in 
the UK and worldwide.
I hope you will take a few minutes to read this report, which 
highlights the approach of the MARCH Centre and some of its 
achievements to date. Please join us in supporting this vital work to 
deliver on the promises of the UN Millennium Development Goals 
for 2015 and beyond.
Professor Peter Piot
Director and Professor of Global Health
London School of Hygiene & Tropical Medicine
The Centre for Maternal, Adolescent, 
Reproductive, and Child Health (MARCH) 
is the central hub for women’s and 
children’s health within The London 
School of Hygiene & Tropical Medicine, 
with over 150 members creating 
synergies for inter-disciplinary research 
and leadership for change.
MARCH strengthens and promotes innovation, 
evaluation and evidence-based policy making by 
fostering communication and collaboration  
inside and outside the School and between 
researchers and policy makers, across a range 
of settings in over 100 countries and multiple 
disciplines including: 
Description: observational epidemiology, high-quality 
national and global estimates and social science 
theory and analyses are the foundation for linking 
data to action.
Discovery: understanding infections, genetic and 
epigenetic risks, and delineating risks for adverse 
outcomes especially during the two crucial windows 
of pregnancy and the first two years after birth, and 
adolescence.
Development: innovations in diagnostics,  
devices and strategies, for example to improve 
quality of care.
Delivery: a major strength is in intervention and 
health systems research, with economic and policy 
analysis.
Currently we have over 80 multidisciplinary research 
studies, coordinated by world leading scientists 
and covering themes along the continuum of care 
including:
■ young people’s health and behaviours 
■ family planning and reproductive health
■ infertility
■ maternal mortality and morbidity
■ newborn health, preterm birth and stillbirths
■ nutrition and child health, growth and development
■ diagnosis, prevention and treatment for infectious 
disease in pregnancy and childhood.
About MARCH
Director:  
Professor Joy Lawn
Joy.Lawn@lshtm.ac.uk
Twitter: @joylawn
Courtesy of Felicia Webb
Courtesy of Bill & Melinda Gates Foundation
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Unfinished agenda and future delivery post-2015 Delivering solutions through the lifecycle
Progress in the MDG era 
The Millennium Development Goals (MDGs) era 
ends in 2015 with remarkable successes and yet an 
unfinished agenda for 9 million maternal, newborn 
and child deaths and stillbirths, linked to HIV, malaria 
and undernutrition, as well as unmet needs for family 
planning. Adolescent health was missing in the MDG 
metrics. 
There is also a shifting global health agenda with transitions 
from death to disability, and newer risks such as obesity, NCDs, 
urbanisation, mental health disorders, injuries and climate 
change. Infectious diseases, both the old and the new, are not 
over yet.  The research community needs to be ahead of these 
shifts since studies often take two to ten years to influence policy. 
Data for action to accelerate progress  
post-2015
With new and ambitious goals to end preventable maternal 
newborn and child mortality and to address universal reproductive 
health care, prioritising based on data is even more critical.  
MARCH members and academics in the School contribute to 
many of the epidemiological analyses, generating data and 
informing the future agenda. 
■ Where in the world?
Africa is increasingly important, with 12% of 
the world’s population yet over half of the 
burden for maternal and child deaths. If 
current trends continue with increasing 
births and slower progress for reducing 
deaths, then by 2030 Africa will 
account for almost two-thirds of child 
deaths worldwide.
Asia accounts for more than half of 
the world’s population and is critical 
for any global progress. 
By 2030 most of the world’s births 
will be in middle income countries 
making more complex care feasible, 
and also shifting the centre of gravity 
for innovation to these regions.
Around the world, the School has a history 
of partnerships in over 100 countries (see 
pages 10 - 13).
■ When in the lifecycle?
Two thirds of the deaths for women, babies and children happen 
at birth - investing at this time gives a triple return on investment, 
or even quadruple if counting the lost development potential from 
neonatal complications and poor in-utero growth of babies, leading 
to stunting in children. Care at birth and family planning are two 
of the most cost-effective  health strategies, also contributing to 
economic development. 
MARCH focuses on a lifecycle approach, including the key time 
around birth.
■ Who?
A focus on girls is important throughout the lifecycle and 
especially when girls and women are disadvantaged. This may 
be by gender selective abortions, less preference for nutritional 
inputs than boys, lower careseeking, female genital mutilation 
(FGM), missing out on education, child marriage, or violence 
against women. MARCH includes members working on all these 
issues and also the important linkages for boys and men.
MARCH through the lifecycle 
Our work is organised around three 
priority points in the lifecycle:
Adolescents and young people 
achieving healthy 
transitions
Births that are wanted, pregnancies that are 
safe, babies alive 
and thriving
Children with a healthy start, optimal growth 
and development
Investing in women’s and children’s health can give a 
9-fold return in economic gains, and lower health system 
costs. The most effective investment points are family 
planning, care at birth, child and adolescent health.
Lancet Commission on Investing in Health
Courtesy of Molly Miller-Petrie
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Adolescents and young people 
achieving healthy transitions
What is the A theme about?
This theme focuses on the health of 
adolescents and young people. There 
are four main reasons why public health 
should focus on this group:
Neglected group. Young people aged 10-24 are 
often neglected in health interventions, despite 
both the importance of supporting young adults to 
realise their potential, and the key role of health 
and health behaviours in young adulthood in 
shaping health in later life. 
Demographic transition. In most high and  
middle income countries there are more 
adolescents (10-19 years) than children (0-9 years). 
Low income countries are rapidly approaching 
a similar demographic balance, with more than 
one in four of the total population aged 10-19 
owing to falling fertility rates and dramatic recent 
improvements in child survival. This provides a 
one-time potential economic dividend to countries 
whose populations are replete with young adults 
going through their most productive period of life. 
But to realise this potential, those young adults 
must be healthy, educated and employed.
Epidemiological transition. The burden from 
infectious diseases is decreasing, especially 
in young children. On the other hand, non-
communicable health conditions with origins in 
children and young people such as injuries, mental 
ill health, cardiovascular disease, diabetes and 
obesity have been increasing dramatically.
Effective interventions. We have an increasing 
range of effective interventions to prevent these 
illnesses through taking action during childhood and 
adolescence. 
What does the A theme do?
Staff from across the School’s three faculties are 
engaged in research and teaching to improve the 
health and wellbeing of young people, and to help 
them realise their potential. Work in the A theme 
ranges from descriptive quantitative and qualitative 
research on the burden of disease in this age 
range, to in-depth anthropological and sociological 
enquiries into social aspects of young people’s 
health and transitions, to development, testing and 
evaluation of novel interventions.
Disciplines cover a wide spectrum across the 
social, behavioural, epidemiological and clinical 
sciences. Topic areas cover the full range of the key 
health issues of young people, including sexual and 
reproductive health, use of tobacco, alcohol and 
other psychoactive drugs, injuries, mental health, 
nutrition and exercise, and infectious diseases.
The A theme organises seminars and workshops 
related to the health of adolescents and young 
people (often jointly with the Child and Adolescent 
Health Centre in University College London) and 
creates opportunities for staff to develop multi-
disciplinary collaborations. 
Examples of research: 
(more examples on pages 10-13) 
■  A qualitative longitudinal study of young people’s 
experiences of growing up with HIV in UK, 
Uganda, Zimbabwe and USA and how this affects 
transitions to adulthood.
■ Epidemiological studies of individual, family, 
community and school-level factors influencing 
school dropout and school absenteeism in 
Malawi.
AAdolescents
and young 
people... healthy 
transitions
In the UK, 10-19 year olds outnumber 0-9 
year olds. In Europe, mortality rates among young men 
aged 15-19 are higher than for 1-4 year-olds. 
Lancet Adolescent series 2011
One billion adolescents 
(10-19 yrs) alive today: 
the largest ever youth generation. 
Are we investing for their future?  
WHO Health for the World’s Adolescents. 
Report 2014
■ An epidemiological study in Malawi 
showed a link between earlier 
age at menarche and age at first 
sex, age at marriage, and herpes 
simplex type-2 infection.
■ A trial in Bulawayo Zimbabwe 
of a single session, football-
based voluntary medical male 
circumcision promotion intervention 
(Make the Cut) showed that 
it increased the uptake of 
circumcision ten-fold over the 4.5 
month follow-up period.
Examples of outputs:
■ A Theme members were involved 
in the recent Lancet Series on 
adolescent health, and are also 
co-leaders for the current Lancet 
Commission on Adolescent Health 
and Wellbeing.
■ Jointly with WHO, the School runs 
an annual two-week short course 
of adolescent health in low and 
middle income countries, which has 
trained 70 mid-career professionals 
during its first 5 years. The 
course has also spawned annual 
regional courses for Africa run 
by collaborators in the Obafemi 
Awolowo University in Nigeria, and 
for Asia run by the Public Health 
Foundation of India.
Worldwide the 
most common 
causes of death 
for adolescents 
are road traffic 
injuries, suicide, 
interpersonal 
violence, HIV and 
other infections. 
Courtesy of Neil Spicer
Courtesy of David Ross
Courtesy of Jeff Holt
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Births that are wanted and safe
What is the B theme about? 
Every year there are over 200 million 
pregnancies in the world, wanted and 
unwanted, that result in a healthy baby 
delivered by a healthy woman, or an 
adverse birth outcome that afflicts mother, 
child, or both. 
In 2013, an estimated 289,000 women lost their 
lives in childbirth, 2.9 million babies died in the 
neonatal period and 2.6 million were stillbirths.  
One in every four couples in the developing world 
has been affected by infertility with global levels 
of primary and secondary infertility relatively 
unchanged between 1990 and 2010.
The ‘Birth’ theme covers issues related to 
preconception, family planning, pregnancy, care 
at birth and the immediate postnatal period. 
Topics covered by MARCH members include 
infertility, menstrual hygiene, induced abortion 
and miscarriage, contraceptive needs and unmet 
needs, obstetric complications, maternal mortality, 
prevention and treatment of infectious and chronic 
diseases during pregnancy, stillbirth, and neonatal 
morbidity and mortality, particularly preterm birth.
What does the B theme do?
The ‘Birth’ theme includes anthropologists, 
paediatricians, epidemiologists, lab scientists, 
economists, demographers, statisticians as well as 
several other disciplines. 
MARCH members play a leading role in quantifying 
the burden of diseases as well as testing 
interventions or technologies designed to prevent 
and to treat complications of birth and deaths, in 
high- and low-resource countries. MARCH members 
also study how maternity, antenatal, postnatal and 
reproductive health services can be used as a 
platform to deliver services that prevent and control 
infections such as HIV, malaria, and other public 
health problems such as violence against women.
Examples of research: 
(more examples on pages 10-13)
■ A multi-country randomised controlled trial of 
tranexamic acid administered to women who have 
postpartum haemorrhage involving more than 
15,000 women across 19 countries (Professor 
Ian Roberts, Haleema Shakur and colleagues).
■ Development of simple diagnostic tools to 
be used in primary health care settings with 
particular attention to syphilis (Professors 
Rosanna Peeling, David Mabey and colleagues).
■ Conducting clinical trials designed to prevent 
and treat malaria infection during pregnancy 
(Professors Brian Greenwood, Daniel 
Chandramohan and colleagues).
■ Three large evaluations of multi-country 
intervention projects of maternal and neonatal 
health interventions as well as family planning 
funded by the Bill and Melinda Gates Foundation 
(Professor Joanna Schellenberg), Markets 
Evaluation Team (Professor Oona Campbell), and 
EVA-PMDUP (Evaluation of Prevention of Maternal 
Mortality and Unwanted Pregnancy) funded by the 
UK’s Department for International Development.
■ Work with the Royal College of Obstetricians  
and Gynaecologists examining variations in 
maternity care in the UK (Professor Jan van der 
Meulen and colleagues).
Examples of outputs:
Members of MARCH are involved in several high-
profile, policy-relevant initiatives. For example The 
Lancet Every Newborn Series (2014) provided the 
basis for the Every Newborn action plan with post-
2015 targets for reducing neonatal mortality and 
stillbirth rates. Others have played a lead role in the 
WHO report on violence against women (2013) and 
the Family Planning 2020 summit (2012) and the 
Nutrition for Growth Summit (2013). 
We have hosted several events with global partners 
including, for example, Save the Children’s State 
of the World’s Mothers report (2013), a recent 
symposium on the effects of obesity on maternal 
and neonatal health, and the launch of The Lancet 
Midwifery Series (2014).
BBirths
…Wanted  
and safe
By 2030 one in three births will
be in Africa but almost two-thirds of child
deaths will be African – unless we act 
now to address family planning and child 
mortality. 
34 countries are 
projected to meet the 
Millennium Development 
Goal to halve unmet 
need for family planning 
compared to 1990. 
9 of these countries are 
in sub-Saharan Africa,  
6 in Eastern Africa.
Of 26 countries with 
>50% unmet need for 
family planning all but 
one are in sub-Saharan 
Africa, mostly in Central 
and Western Africa.
For every woman who dies in 
childbirth, around 20 more suffer 
injury, infection or disease – 
approximately 10 million women 
each year, along with 5.5 million 
babies who die as stillbirths or 
neonatal deaths.
Courtesy of Save the Children
Courtesy of Save the Children
Courtesy of Save the Children
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Children that survive and thrive
What is the C theme about?
During the MDG era deaths for children 
under five have been halved. Our focus is 
on ending preventable child deaths, and 
improving child development and nutrition. 
Despite significant progress in reducing childhood 
mortality there are still more than 6.7 million 
deaths of children under five each year (1 child 
every 5 seconds), almost half occurring in the first 
month of life. 
In 2013 preterm birth complications became the 
leading cause of child deaths at 1 million per year, 
followed by pneumonia. The causes with the largest 
reductions since 2000 were pneumonia, diarrhoea 
and measles, together accounting for almost half 
of the overall reduction. Those with the slowest 
progress (<3% per year) included preterm birth, 
congenital conditions, neonatal sepsis, injury.
Many of these deaths could be prevented if we 
reached every woman and every child with evidence-
based interventions, particularly care of the 
newborn and prevention, diagnosis and treatment 
of infections. Evaluating how best to implement, 
overcoming systems barriers and promoting 
behaviour change, is critical. The School excels at 
this research as well as more upstream discovery 
and delivery research.
Worldwide, as more children survive, increasing 
attention is focused on healthy childhood: nutrition, 
growth, development and the prevention and 
management of injury and disability, maximising 
health in later life.
What does the C theme do?
MARCH is uniquely positioned to address the 
priority challenges in child and newborn health.  
As one of the world’s largest schools of public 
health, London School of Hygiene & Tropical 
Medicine researchers work across a range of 
disciplines: from molecular biologists discovering 
vaccine targets and biomarkers of infections, 
and immunologists unpacking the relationship 
between host immunity and infection, through to 
social scientists, epidemiologists, mathematical 
modellers and health economists, using qualitative 
and quantitative approaches to describing and 
understanding newborn and child health, and to 
design and evaluate interventions to address key 
challenges. 
School researchers also lead multidisciplinary 
research in collaboration with other sectors, for 
example research on injury and violence prevention 
in schools, collaborative research on nutrition and 
agriculture, innovative work on water, sanitation and 
hygiene (WASH), and research on the prevalence 
and impact of disability in childhood. 
Examples of research include: 
(more examples on pages 10-13)
■ A mother’s diet and her child’s DNA 
Researchers from the School led by Branwen 
Hennig and Andrew Prentice have produced 
the first evidence in humans that a mother’s 
diet before conception can lead to epigenetic 
modifications in her child’s DNA, with the 
potential to permanently affect lifelong health.  
By utilising a unique ‘experiment of nature’ in 
rural Gambia, where there is marked seasonal 
variation in people’s dietary patterns, they 
found that infants from dry season conceptions 
had lower rates of DNA methylation than those 
conceived during the wet season, altering how 
the genes will be interpreted with potentially life-
long impact. 
■ SPRING (Sustainable Program Incorporating 
Nutrition and Games) is a five year programme 
in Haryana, India and Rawalpindi, Pakistan 
funded by the Wellcome Trust to develop and 
evaluate an innovative, integrated strategy to 
reduce child deaths and improve child growth 
and development. The intervention consists 
of a community worker home visit package 
from pregnancy through the first 2 years of life 
CChildren
…Survive and 
thrive
At current rates of progress it will be over a century before 
a baby born in Africa has the same chance of surviving their 
first month as a baby born in Europe or USA.
Lancet Every Newborn series
Donor funding for child health 
to 75 Countdown countries more than 
doubled during the last decade, with 
almost all being for immunisation, HIV 
and malaria.
1 in 4 of 
children under-
five are stunted, 
accounting for  
over one third 
of child deaths 
plus millions with 
lost development 
potential. 
Courtesy of Molly Miller-Petrie
Courtesy of Shunmay Yeung
Courtesy of March of Dimes
Courtesy of Molly Miller-Petrie
to promote optimum child care 
practices, including infant and 
young child feeding, mother-child 
interaction and play. The evaluation 
is through a cluster randomised 
controlled trials in each site.  
■ SuperAmma handwashing 
promotion programme in rural India 
represents leadership in behaviour 
change research that also engages 
the private sector. Through the use 
of a fictional character (SuperAmma) 
and emotional motivators the 
intervention was shown to increase 
handwashing with soap at key times 
by 31%.
■ TRAC (Tracking Resistance 
to Artemisinin Collaboration)  
Resistance to artemisinins, the 
first-line treatment for falciparum 
malaria,  is a major threat to 
children.  TRAC is conducting 
research to track and limit the 
spread of resistance, including 
assessments of treatment seeking 
and antimalarial drug use and 
quality in Southeast Asia. 
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MARCH around the world
The Centre has partnerships in around 100 
countries and is involved in more than 80 studies 
globally. Here are a few examples, in addition to 
those listed throughout this report
Healthy schools- Reducing dengue and diarrheal 
diseases in primary schools in Columbia 
Drinking water may contain the micro-organisms that 
cause diarrhoea, and also mosquitoes which transmit 
dengue need water to lay their eggs in. Funded by the 
Research Council of Norway and the Lazos de Calandaima 
Foundation, this study assesses two sets of interventions 
to reduce these diseases in children attending schools in 
rural Cundinamarca, Columbia. Schools are randomised 
to receive one or other of the sets of interventions, or 
neither, or both. We measure the effect in terms of school 
absences due to diarrhoea, and the occurrence of the 
dengue mosquitoes (Aedes aegypti). 
Contact: Neal.Alexander@lshtm.ac.uk
Reducing child mortality through mass media  
Burkina Faso
The first robust trial of the impact of mass media on 
health outcomes in a low-income setting is evaluating 
whether 60- second health messages and long format 
programmes broadcast on local radio can save lives. 
The trial is designed to detect a 20% reduction in child 
mortality at the end of the radio campaign. Funded by 
the Wellcome Trust and Planet Wheeler Foundation, 
Simon Cousens and Sophie Sarrassat from the School 
are working in partnership with Development Media 
International, Centre Muraz, and the Ministry of Health 
of Burkina Faso.
Contact: Simon.Cousens@lshtm.ac.uk
Health systems and financing RESYST, 
India, Thailand and Vietnam
Resilient and Responsive Health Systems 
(RESYST) is an international research 
consortium which aims to enhance the 
resilience and responsiveness of health 
systems to promote health equity. Led by 
Kara Hanson, and funded by UKAID, RESYST 
is working with IHPP THAILAND, the Indian 
Institute of Technology and the Health Strategy 
and Policy Institute, Vietnam. The research 
focuses on the three critical components 
of health systems: financing, workforce and 
governance including approaches. Examples 
of focus include results based financing and 
raising and using tax revenues for health 
services.
Contact: Kara.Hanson@lshtm.ac.uk  
Twitter @RESYSTresearch
HIV, nutrition and childhood infections Zambia
Children maternally exposed to HIV in utero have reduced immunity to other 
viruses, yet infection outcomes can be reduced by breastfeeding and vitamin/
mineral supplements. However, some infections as HIV and human cytomegalovirus, 
HCMV, can be transmitted in breastmilk. Suzanne Filteau and Ursula Gompels with 
Lackson Kasonka, Mwaka Monze and colleagues have been studying effects of these 
interventions on poliovirus antibodies and effects of HCMV in Zambian children. The 
team is now testing lipid based dietary supplements for HIV patients in the Nutritional 
Support for Africans Starting Antiretroviral Therapy (NUSTART) trial and following 
breastmilk infections.
Contact: Suzanne.Filteau@lshtm.ac.uk  
and Ursula.Gompels@lshtm.ac.uk
Healthy transitions to adulthood, Kenya, Ghana
This study is designing a package of adolescent health 
services, and exploring how best to deliver this care to 
young people. David Ross and Aoife Doyle are working 
with Margaret Gyapong and colleagues at Dodowa 
Health Research Unit of Ghana Health Service, the 
INDEPTH Secretariat in Accra, and the Wellcome Trust-
KEMRI Unit in Kenya with Hewlett Foundation funding.
Contact: David.Ross@lshtm.ac.uk   
Twitter @LSHTM_MARCH
What young people think about sex and what 
they do, UK 
The sixteen18 project examines a broad range 
of practices, including oral, vaginal and anal sex. 
Based on interviews with 130 young men and 
women aged 16-18 in England, the study aims to 
understand where, when and with whom young 
people would expect different practices to occur, 
and what those practices mean to them. The study, 
led by Cicely Marston and funded by the ESRC 
has shown different ways the social environment 
around young people can influence practices, 
including for instance, normalising coercion of 
women into anal sex.
Contact: Cicely.Marston@lshtm.ac.uk
INSIST, community-based interventions for newborn 
survival, Tanzania
Maternal and newborn health is an urgent priority 
in Africa yet half of births are at home. Joanna 
Schellenberg and colleagues are working with Fatuma 
Manzi at Ifakara Health Institute on Improving Newborn 
Survival in Southern Tanzania (INSIST), a community-
based trial funded by the Gates Foundation though 
Saving Newborn Lives, Save the Children. A network of 
over 800 trained local female volunteers visit women 
and families before and after birth to promote healthy 
practices including clean birth, breastfeeding and extra 
care for small babies. 
Contact: Joanna.Schellenberg@lshtm.ac.uk
Soapbox: clean birth practices in reality 
Given the opportunity of increasing facility births, the 
Soapbox Collaborative aims to research and improve 
clean, safe delivery care to reduce maternal and 
newborn infections.  In Zanzibar, in collaboration with 
the Ministry of Health and WaterAid, funded by SHARE, 
we are undertaking an innovative assessment of water 
sanitation and hygiene (WASH) in all facilities. In The 
Gambia there is a mixed-methods feasibility study of 
Clean Birth Kits supply in health centres.
Contact: info@soapboxcollaborative.org 
www.soapboxcollaborative.org
User-fee free health for mothers and newborns 
Burkina Faso, Benin, Mali
FEMHealth (Fee exemption for maternal health care) is 
a study evaluating the effects on maternal and newborn 
outcomes if user fees are removed for emergency care 
in Mali, Morocco, Benin and Burkina Faso. In addition 
multidisciplinary research is being conducted on the 
impact of pregnancy on women’s economic activity 
in Burkina Faso, investigating how investments in 
reproductive health might contribute to reducing poverty 
and fostering economic development and equity. The 
project is coordinated by Aberdeen Univ. The LSHTM team 
is led by Veronique Filippi and Carine Ronsmans and is 
funded by the EU. 
Contact: Veronique.Filippi@lshtm.ac.uk 
Maternal healthcare markets Evaluation Team
The School’s Maternal healthcare markets 
Evaluation Team (MET) is seeking to understand 
the role of the private sector in providing 
maternal health care as part of its evaluation 
of the Merck, Sharpe and Dome (MSD) for 
Mothers initiative. Projects being evaluated 
include social franchising for maternal health in 
India and Uganda and private operated supply 
chains for family planning in Senegal. Led by 
Caroline Lynch and Catherine Goodman, the 
team are also investigating where women seek 
care worldwide through analysis of demographic 
health surveys and examining the nature of 
competition where the private sector is providing 
maternal care. MSD for Mothers is a 10-year, 
US $500 million initiative to reduce maternal 
mortality around the world. 
Contact: Caroline.Lynch@lshtm.ac.uk
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MenAfriCar (African Meningococcal 
Carriage Consortium) 
This multi-country research is coordinated by the 
School’s Professor Brian Greenwood, linking with many 
African institutions and global experts with funding 
by The Wellcome Trust and The Bill & Melinda Gates 
Foundation. The study is examining how meningococcal 
meningitis spreads across the “meningitis belt” in 
sub-Saharan Africa, and documenting the impact of a 
new meningitis vaccine. The vaccine was introduced in 
Burkina Faso, Mali and Niger in 2010.  In Chad almost 
2 million doses were given and recently shown to be 
highly effective at preventing invasive meningococcal 
disease and carriage. 
Contact: Brian.Greenwood@lshtm.ac.uk 
Website: www.menafricar.org
ALPHA network: the power of shared data, East and Southern Africa 
ALPHA network: the power of shared data, East and Southern Africa. The network for Analysis of Longitudinal 
Population based HIV data in Africa (ALPHA) links 10 existing community-based HIV cohort studies, to harmonise 
data and better inform intervention design, monitoring and epidemiological forecasting for HIV. Using their pooled 
data set, ALPHA published the first empirical estimates of HIV contribution to pregnancy-related mortality in 
sub-Saharan Africa. With funding from the Wellcome Trust, and the Bill & Melinda Gates Foundation, ALPHA is co-
ordinated by Basia Zaba and Jim Todd from the School, and works closely with partners in Kenya, Malawi, South 
Africa, Tanzania, Uganda and Zimbabwe. 
Contact: Basia.Zaba@lshtm.ac.uk
ACT for malaria treatment 
Artemisinin-based combination therapy (ACT) is the 
current gold standard of treatment for Plasmodium 
falciparum malaria, a major cause of childhood 
illness and death. The ACT Consortium aims to 
improve access to and targeting of ACT drugs, as 
well as to assess their quality and safety through a 
range of interdisciplinary approaches including large 
cluster randomized control trials, qualitative and 
economic studies. Funded by the Bill & Melinda Gates 
Foundation, the Consortium is a global research 
partnership involving over 40 co-investigators from 
Africa, Asia, Europe and the US working on 25 projects 
across 10 countries.
Contact: David.Schellenberg@lshtm.ac.uk 
Website: www.actconsortium.org
E4A to save mothers and 
newborns Africa regional
Evidence for Action (E4A) a five year programme 
to improve maternal and newborn survival in 
six sub-Saharan countries (Ethiopia, Ghana, 
Malawi, Nigeria, Sierra Leone and Tanzania) 
through better use of information, evidence-
based advocacy, and effective accountability. 
The consortium of 6 partners (Options, The 
London School for Hygiene & Tropical Medicine, 
University of Aberdeen, UCL, University of 
Southampton and Advocacy International) is 
funded by the UKAID.
Contact: Carinne.Ronsmans@lshtm.ac.uk 
Twitter: @mamaye
MARCH around the world
Examples of multi-country projects and consortia
IDEAS: Evidence to improve 
maternal and newborn health
The IDEAS project uses measurement and evaluation to 
understand which health innovations and programmes 
deliver the greatest impact on maternal and newborn 
survival at scale, as well as why and how they work. 
Working in Ethiopia, North-Eastern Nigeria and the state 
of Uttar Pradesh in India, the multidisciplinary team, 
led by Professor Joanna Schellenberg, aims to improve 
the health and survival of mothers and babies through 
generating evidence to inform policy and practice. The 
project also hosts the IDEAS Technical Resource Centre 
which strengthens the measurement, learning and 
evaluation capacity of colleagues from collaborating 
projects, promotes collaboration, and stimulates 
exchange of expertise. IDEAS is funded by the Bill & 
Melinda Gates Foundation.
Contact: ideas@lshtm.ac.uk 
Website: ideas.lshtm.ac.uk  
Twitter: @LSHTM_IDEAS
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Leadership for the next generation
Our vision is to identify the next 
generation of leaders for women’s and 
children’s health and help to skill them 
by maximising collaborations inside and 
outside the School.
Leadership
As well as formal qualifications in public health, 
MARCH is building on long-term partnerships with 
academic and research institutions and networks, 
particularly in Africa, to strategically identify and 
strengthen leaders and centres of excellence 
around the MARCH themes of A, B and C.
Several of our staff contribute to leadership 
development whilst based overseas. Recent 
examples include Professor Carine Ronsmans 
seconded to Sichuan University (China) from 
November 2014, where she is conducting 
collaborative research and supervise postgraduate 
students.
Study at the School
The School has nearly 4000 postgraduate students 
and provides a stimulating environment, with 
state-of-the-art facilities, in which to carry out 
research training. MARCH contributes to teaching 
at the School through short courses, MScs and 
PhDs. Students learn about the burden, assessing 
efficacy of new interventions, and analysing policy, 
costs and implementation strategies for integrating 
interventions into large scale programmes. Working 
with MARCH members based around the world, the 
research degree programme provides opportunities 
for advanced study leading to the degrees of 
DrPH (Doctor of Public Health), MPhil (Master of 
Philosophy) and PhD (Doctor of Philosophy).
As part of the School’s Master’s programmes, 
MARCH members deliver world class courses 
on Reproductive health (e.g. Foundations 
in Reproductive Health and Family Planning 
Programmes), Maternal and Newborn health 
(e.g. Current Issues in Safe Motherhood and 
Professor Joy Lawn Dr Tanya Marchant
MARCH team
Director Professor Joy Lawn
Deputy   Dr Tanya Marchant 
Centre Leadership Team:
A (Adolescents) Professor David Ross
 Dr Cicely Marston
B (Births) Dr Véronique Filippi
   Mr Matthew Chico
C (Children) Professor Andrew Prentice
 Dr Shunmay Yeung
Experts drawn from School faculties 
representing a continuum of research in 
women’s and children’s health.
Courtesy of Anna Kagstrom
Perinatal Health), and Child Health 
(e.g. mother and child nutrition, 
epidemiology and control of 
malaria). The joint LSHTM/World 
Health Organization annual short 
course on Adolescent Health in 
Low and Middle Income Countries, 
launched in 2010, addresses health 
needs of the largest ever cohort of 
adolescents.
I feel proud to be 
a London School 
of Hygiene & 
Tropical Medicine 
alumnus. The focus 
on building skills of 
health professionals 
throughout the 
world has been 
achieved in many 
ways. Just look at 
the number of school 
alumni working in 
ministries of health 
in developed and 
developing countries, 
international 
organisations and 
NGOs.
Dr Elizabeth Mason (MSc 
Community Medicine,
1984) retired Director, 
Department of Child and 
Adolescent Health, World 
Health Organization.
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Delivering on our future 
Delivery priorities
In the short term the most gains will 
come from immediate implementation 
of high impact care, with innovation and 
implementation research to increase 
coverage and close equity and quality 
gaps. This focus will be especially 
important for the 30 or so countries that 
need to more than double progress to 
reach 2030 targets for ending preventable 
maternal, newborn and child deaths.
However, it is also crucial to invest 
now in discovery science, ensuring 
new solutions whether vaccines, newer 
antimicrobials, and other drugs and 
devices, or innovations in service delivery 
and behaviour change. It is particularly 
important to link women’s and children’s 
health with new agendas – NCDs mental 
health and intersectoral issues such as 
Water Sanitation and Hygiene (WASH), 
education, and economic growth. 
There are major burdens where solutions 
are lacking notably preterm birth, stunting, 
and outcomes for HIV exposed but non 
infected infants where the School has 
world leading scientists. Inter-generational 
impact and epigenetics hold promise 
for breakthroughs, with potentially more 
major impact in low and middle income 
countries. 
The MARCH Centre has strategic 
collaborations with other Centres in the 
School such as the Centre for Evaluation, 
and those for Malaria, Vaccines, 
Diagnostics, Mental Health, Disability 
and Non Communicable Diseases. We 
also have many alliances with global 
and regional partners, particularly in the 
United Nations agencies such as WHO, 
UNICEF and UNFPA.  
In the post-2015 world where health 
fits in the wider context of sustainable 
development, greater progress and bigger 
breakthroughs occur when “unlike minds” 
collaborate - from around the globe, from 
different disciplines and focusing on 
different parts of the lifecycle.
MARCH and the School can bring such 
breakthroughs more and more - in 
discovery science, innovation for health 
system delivery, and a deliberate 
and strategic approach to leadership 
development.
 
Please join with us to improve 
health for women and children 
around the world.
march@lshtm.ac.uk
http://march.lshtm.ac.uk
Twitter: @MARCH_LSHTM 
The world community must unite 
in a shared vision of healthy women and 
children at the heart of the Post-2015 
Sustainable Development Agenda. 
Erna Solberg, Prime Minister of Norway
We cannot rest until these 
problems (for women and 
children) are solved, and 
we cannot solve these 
problems alone.
Hillary Clinton, June 2014 at the 
Partner’s Forum
Courtesy of OmPrasad Gautam
Courtesy of Ulrika Baker
Courtesy of Save the Children
Courtesy of Save the Children
Report written and edited by Joy Lawn, Tanya Marchant and the MARCH team 
(David Ross, Cicely Marston, Véronique Filipi, Matthew Chico and Shunmay Yeung). 
Design and layout by Chris Matthews.
Cover image by Felicia Webb.
